Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid
Open Access
- 1 March 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (3) , 519-523
- https://doi.org/10.1128/aac.35.3.519
Abstract
Two associated resistance mechanisms were found in a nalidixic acid-susceptible (4 micrograms/ml) but fluoroquinolone-resistant (8 to 16 micrograms/ml) strain of Escherichia coli Q2 selected under norfloxacin therapy. As compared with the susceptible E. coli Q1 isolated before treatment, changes in outer membrane proteins and lipopolysaccharides in Q2 were associated with a 1.5- to 3-fold decrease in the uptake of fluoroquinolones but not nalidixic acid. A 50% inhibition of DNA synthesis in toluene-permeabilized cells of the resistant strain E. coli Q2 required up to 500-fold increased quantities of fluoroquinolones, whereas such inhibition was obtained in both E. coli Q1 and Q2 with similar amounts of nalidixic acid. Selection from E. coli Q1 on norfloxacin of one-step resistant mutants resembling E. coli Q2 was unsuccessful. From these results we infer that a decrease in outer membrane permeability, associated with a peculiar alteration of the DNA gyrase, was responsible for the unusual quinolone resistance phenotype of E. coli Q2.Keywords
This publication has 16 references indexed in Scilit:
- Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulationAntimicrobial Agents and Chemotherapy, 1989
- Endogenous active efflux of norfloxacin in susceptible Escherichia coliAntimicrobial Agents and Chemotherapy, 1988
- Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1988
- Norfloxacin resistance in a clinical isolate of Escherichia coliAntimicrobial Agents and Chemotherapy, 1987
- Mutations producing resistance to norfloxacin in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1987
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- Inhibition of DNA replication in vitro by pefloxacinFEBS Letters, 1982
- Properties of the Penicillin‐Binding Proteins of Escherichia coli K12European Journal of Biochemistry, 1977
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970